206 related articles for article (PubMed ID: 28062368)
1. Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy.
Shin DH; Kwon GS
Int J Pharm; 2017 Feb; 518(1-2):307-311. PubMed ID: 28062368
[TBL] [Abstract][Full Text] [Related]
2. Pre-clinical evaluation of a themosensitive gel containing epothilone B and mTOR/Hsp90 targeted agents in an ovarian tumor model.
Shin DH; Kwon GS
J Control Release; 2017 Dec; 268():176-183. PubMed ID: 29056443
[TBL] [Abstract][Full Text] [Related]
3. A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs.
Shin HC; Alani AW; Cho H; Bae Y; Kolesar JM; Kwon GS
Mol Pharm; 2011 Aug; 8(4):1257-65. PubMed ID: 21630670
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.
Shin HC; Cho H; Lai TC; Kozak KR; Kolesar JM; Kwon GS
J Control Release; 2012 Oct; 163(1):93-9. PubMed ID: 22549011
[TBL] [Abstract][Full Text] [Related]
5. Oligo(Lactic Acid)
Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
[TBL] [Abstract][Full Text] [Related]
6. Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery.
Cho H; Kwon GS
J Drug Target; 2014 Aug; 22(7):669-77. PubMed ID: 24964052
[TBL] [Abstract][Full Text] [Related]
7. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
Tam YT; Gao J; Kwon GS
J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
[TBL] [Abstract][Full Text] [Related]
8. Triolimus: A Multi-Drug Loaded Polymeric Micelle Containing Paclitaxel, 17-AAG, and Rapamycin as a Novel Radiosensitizer.
Tomoda K; Tam YT; Cho H; Buehler D; Kozak KR; Kwon GS
Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27365266
[TBL] [Abstract][Full Text] [Related]
9. Dual-drug loaded micelle for combinatorial therapy targeting HIF and mTOR signaling pathways for ovarian cancer treatment.
Doddapaneni BS; Al-Fatease AM; Rao DA; Alani AWG
J Control Release; 2019 Aug; 307():272-281. PubMed ID: 31260753
[TBL] [Abstract][Full Text] [Related]
10. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
11. Multi-drug loaded micelles delivering chemotherapy and targeted therapies directed against HSP90 and the PI3K/AKT/mTOR pathway in prostate cancer.
Le B; Powers GL; Tam YT; Schumacher N; Malinowski RL; Steinke L; Kwon G; Marker PC
PLoS One; 2017; 12(3):e0174658. PubMed ID: 28350865
[TBL] [Abstract][Full Text] [Related]
12. PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery.
Cho H; Gao J; Kwon GS
J Control Release; 2016 Oct; 240():191-201. PubMed ID: 26699425
[TBL] [Abstract][Full Text] [Related]
13. Solubilization of sagopilone, a poorly water-soluble anticancer drug, using polymeric micelles for parenteral delivery.
Richter A; Olbrich C; Krause M; Kissel T
Int J Pharm; 2010 Apr; 389(1-2):244-53. PubMed ID: 20100557
[TBL] [Abstract][Full Text] [Related]
14. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
Saxena V; Hussain MD
Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704
[TBL] [Abstract][Full Text] [Related]
15. Tumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-histidine).
Lee ES; Oh KT; Kim D; Youn YS; Bae YH
J Control Release; 2007 Oct; 123(1):19-26. PubMed ID: 17826863
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
Chandran T; Katragadda U; Teng Q; Tan C
Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effect of targeted biodegradable epothilone B and rapamycin co-loaded nanocarriers on breast cancer cells.
Zajdel A; Wilczok A; Jelonek K; Kaps A; Musiał-Kulik M; Kasperczyk J
J Biomed Mater Res A; 2021 Sep; 109(9):1693-1700. PubMed ID: 33719211
[TBL] [Abstract][Full Text] [Related]
18. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles.
Forrest ML; Zhao A; Won CY; Malick AW; Kwon GS
J Control Release; 2006 Nov; 116(2):139-49. PubMed ID: 16926059
[TBL] [Abstract][Full Text] [Related]
19. Multidrug PLA-PEG filomicelles for concurrent delivery of anticancer drugs-The influence of drug-drug and drug-polymer interactions on drug loading and release properties.
Jelonek K; Li S; Kaczmarczyk B; Marcinkowski A; Orchel A; Musiał-Kulik M; Kasperczyk J
Int J Pharm; 2016 Aug; 510(1):365-74. PubMed ID: 27346726
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of Triolimus: a novel multidrug-loaded micelle containing Paclitaxel, Rapamycin, and 17-AAG.
Hasenstein JR; Shin HC; Kasmerchak K; Buehler D; Kwon GS; Kozak KR
Mol Cancer Ther; 2012 Oct; 11(10):2233-42. PubMed ID: 22896668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
